MapLight Therapeutics, Inc.
MPLT
$20.55
$0.613.06%
NASDAQ
| 09/30/2025 | 06/30/2025 | 09/30/2024 | |||
|---|---|---|---|---|---|
| Net Income | 1.43% | -33.60% | -3.35% | ||
| Total Depreciation and Amortization | 0.00% | -18.07% | 8.09% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | -112.50% | 450.90% | -175.05% | ||
| Change in Net Operating Assets | 53.78% | -46.08% | -405.96% | ||
| Cash from Operations | 6.41% | -32.94% | -13.24% | ||
| Capital Expenditure | 53.03% | -- | -29.86% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -874.61% | -53.33% | 107.42% | ||
| Cash from Investing | -877.72% | -53.51% | 107.09% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | 3,366.67% | -40.00% | -97.32% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -476.10% | -205.77% | 89.08% | ||
| Cash from Financing | 127,060.26% | -231.91% | 87.81% | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 283.83% | -240.21% | 91.90% | ||